JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Escitalopram Treatment of Night Eating Syndrome

Not Applicable

Completed

Conditions: Night Eating Syndrome

Interventions: Drug: Placebo
Drug: Escitalopram

First Posted Date: 2008-03-14

Last Posted Date: 2016-06-29

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT00636649

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Saint Louis University, St. Louis, Missouri, United States

BraveNet Integrative Medicine Descriptive Study

Completed

Conditions: Healthy

First Posted Date: 2008-03-14

Last Posted Date: 2011-06-14

Lead Sponsor: Duke University

Target Recruit Count: 4340

Registration Number: NCT00636779

Locations: 🇺🇸
University of Maryland Center for Integrative Medicine, Baltimore, Maryland, United States
🇺🇸
Scripps Center for Integrative Medicine, La Jolla, California, United States
🇺🇸
Osher Center for Integrative Medicine, San Francisco, California, United States

and more 5 locations

Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD)

Not Applicable

Completed

Conditions: Stress Disorder, Post Traumatic
Military Sexual Trauma

Interventions: Behavioral: Guided Imagery Audio
Behavioral: Music Audio

First Posted Date: 2008-03-14

Last Posted Date: 2010-05-26

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT00635635

Locations: 🇺🇸
Durham VA Medical Center, Durham, North Carolina, United States

Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001

Completed

Conditions: Metastatic Hormone Refractory Prostate Cancer

First Posted Date: 2008-03-14

Last Posted Date: 2013-12-04

Lead Sponsor: Duke University

Target Recruit Count: 35

Registration Number: NCT00636090

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Genetics of Spina Bifida and Anencephaly

Completed

Conditions: Acrania
Anencephaly

First Posted Date: 2008-03-14

Last Posted Date: 2020-04-02

Lead Sponsor: Duke University

Target Recruit Count: 10000

Registration Number: NCT00636233

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

DAMES: Daughters And MothErS Against Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Standardized Materials Group
Behavioral: Independent Tailored Intervention
Behavioral: Partner-Assisted Tailored Intervention

First Posted Date: 2008-03-07

Last Posted Date: 2017-02-02

Lead Sponsor: Duke University

Target Recruit Count: 482

Registration Number: NCT00630591

Locations: 🇺🇸
U.T. M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Computerized Cognitive Training for Childhood Cancer Survivors

Not Applicable

Terminated

Conditions: Primary Brain Tumor

Interventions: Behavioral: Captain's Log Computer Program

First Posted Date: 2008-03-06

Last Posted Date: 2013-06-03

Lead Sponsor: Duke University

Target Recruit Count: 9

Registration Number: NCT00629395

Locations: 🇺🇸
Duke University Health Systems, Durham, North Carolina, United States

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Not Applicable

Completed

Conditions: Primary Brain Tumor

Interventions: Drug: Innohep

First Posted Date: 2008-03-06

Last Posted Date: 2013-01-07

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT00629447

Locations: 🇺🇸
Duke University Health Systems, Durham, North Carolina, United States

Exercise Training Among Men With Prostate Cancer

Not Applicable

Withdrawn

Conditions: Prostatectomy

Interventions: Behavioral: Exercise

First Posted Date: 2008-02-22

Last Posted Date: 2013-10-28

Lead Sponsor: Duke University

Registration Number: NCT00620932

Locations: 🇺🇸
Duke University Medical Center Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, United States

Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome

Phase 2

Completed

Conditions: Myelodysplastic Syndrome

Interventions: Drug: Decitabine, Arsenic Trioxide and Ascorbic Acid

First Posted Date: 2008-02-22

Last Posted Date: 2013-02-04

Lead Sponsor: Duke University

Target Recruit Count: 7

Registration Number: NCT00621023

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy